Where it comes from
- Made in
- L cells of the ileum and colon
- Sent out by
- Nutrients reaching the lower gut after a meal, alongside the 7-36 amide
- Acts on
- Pancreatic beta cells
- Pancreatic alpha cells
- Stomach
- Hypothalamus and brainstem
What it does
In medicine
- The approved GLP-1 medicines are built on this sequence as much as on 7-36: liraglutide and semaglutide end at glycine 37 1
- Exenatide and lixisenatide come from a lizard peptide that shares about half the sequence
Beyond the body’s own use
- No trial has compared the two forms in people and no medicine distinguishes them, so everything the evidence says of GLP-1 applies to both 1
- Assays that measure it apart from the 7-36 amide exist for research. Why the gut makes two forms at all, and whether the ratio between them shifts in disease or after bariatric surgery, is still open 2
- Its working life is as a reference standard, which is how the gap between “total” and “active” GLP-1 numbers in older papers was traced 2
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.